TriangleHEALTH PROFESSIONAL · SOURCE READING
Treatment Options for Blastic-Phase CML
Source: Chronic Myeloid Leukemia Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: March 13, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Blastic-Phase CML
Treatment options for blastic-phase chronic myeloid leukemia (CML) include:
Targeted therapy with tyrosine kinase inhibitors (TKIs).
Source links and citations
Allogeneic bone marrow transplant (BMT) or stem cell transplant (SCT).
Source links and citations
Continue within this section
Preserved source evidence · Not medical advice